1,101 filings
Page 45 of 56
ARS
2006 FY
LJPC
La Jolla Pharmaceutical Co.
13 Apr 07
Annual report to shareholders
12:00am
DEF 14A
LJPC
La Jolla Pharmaceutical Co.
Definitive proxy
13 Apr 07
12:00am
424B5
LJPC
La Jolla Pharmaceutical Co.
30 Mar 07
Prospectus supplement for primary offering
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
30 Mar 07
La Jolla Pharmaceutical Company Announces Pricing of Common Stock Offering
12:00am
424B5
LJPC
La Jolla Pharmaceutical Co.
20 Mar 07
Prospectus supplement for primary offering
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
20 Mar 07
La Jolla Pharmaceutical Provides Update on Interim Antibody Results from Riquent® Lupus Phase 3 Trial
12:00am
10-K
2006 FY
LJPC
La Jolla Pharmaceutical Co.
Annual report
16 Mar 07
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
8 Mar 07
La Jolla Pharmaceutical Announces Positive Interim Antibody Results from Riquent® Lupus Phase 3 Trial
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
1 Mar 07
Results of Operations and Financial Condition
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
9 Feb 07
La Jolla Pharmaceutical Company to Present at Bio Ceo & Investor Conference
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
9 Feb 07
Departure of Directors or Principal Officers
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
1 Feb 07
La Jolla Pharmaceutical Announces Continued Enrollment Progress and Enhancements to International Phase 3 Riquent® Study
12:00am
10-Q
2006 Q3
LJPC
La Jolla Pharmaceutical Co.
Quarterly report
7 Nov 06
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
7 Nov 06
La Jolla Pharmaceutical Announces Continued Progress with Phase 3 International Riquent® Study
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
3 Nov 06
To Present at Rodman & Renshaw 8TH Annual Healthcare Conference
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
3 Nov 06
Results of Operations and Financial Condition
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
12 Oct 06
La Jolla Pharmaceutical Provides Update on Maa Application In Europe
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
27 Sep 06
La Jolla Pharmaceutical Provides Update on Phase 3 International Riquent® Study
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
20 Sep 06
La Jolla Pharmaceutical Company to Present at Ubs Global Life Sciences Conference
12:00am
8-K
LJPC
La Jolla Pharmaceutical Co.
10 Aug 06
Other Events
12:00am